> The so-called de novo priming of anti-spike Abs that are directed at the relevant circulating SARS-CoV-2 variant prevents natural selection and adaptation of more infectious variants in the unvaccinated population whereas breakthrough boosting on a background of widespread vaccine-mediated immunity / immune memory only precipitates breeding of viral variants with improved immune escape properties.